Veraxa Biotech AG - Post de-SPAC (VRXA) Financial Statements

Veraxa Biotech AG - Post de-SPAC (VRXA) files with the U.S. Securities and Exchange Commission under CIK 0002079109. 10KGenie shows its SEC financial data from SEC filings.

No annual key figures are available in 10KGenie for this company yet. Source: SEC filings.

Open the full financial statements for VRXA in 10KGenie

Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History